Farmaforce Ltd. | Income Statement
Fiscal year is July-June. All values AUD Thousands.
2015
2016
2017
2018
Sales/Revenue
352.70
1,950.80
3,967.50
7,098.30
Cost of Goods Sold (COGS) incl. D&A
-
3,718.00
4,863.70
6,046.90
Gross Income
-
1,767.20
896.20
1,051.40
SG&A Expense
2,196.80
2,071.00
1,355.60
1,368.90
EBIT
1,863.70
-
2,251.80
317.50
Non Operating Income/Expense
0.00
-
2.00
35.50
Interest Expense
187.60
1.90
2.50
-
Pretax Income
2,051.20
3,799.00
2,307.40
454.20
Consolidated Net Income
2,051.20
3,799.00
2,307.40
482.80
Net Income
2,051.20
3,799.00
2,307.40
482.80
Net Income After Extraordinaries
2,051.20
3,799.00
2,307.40
482.80
Net Income Available to Common
2,051.20
3,799.00
2,307.40
482.80
EPS (Basic)
0.02
0.04
0.02
-
Basic Shares Outstanding
130,608.60
87,439.20
127,501.00
127,642.40
EPS (Diluted)
0.02
0.04
0.02
-
Diluted Shares Outstanding
130,608.60
87,439.20
127,501.00
127,642.40
EBITDA
1,844.10
3,799.70
2,203.30
258.80
Non-Operating Interest Income
-
41.10
2.90
-
Equity in Affiliates (Pretax)
-
-
58.00
-
About Farmaforce
View Profile
